Analysts think ARMP stock price could increase by 178%
Jul 31, 2024, 6:26 AM
-16.50%
What does ARMP do
Armata Pharmaceuticals, Inc., a clinical-stage biotech company based in Los Angeles, focuses on developing bacteriophage therapies for antibiotic-resistant bacterial infections, including Pseudomonas aeruginosa and Staphylococcus aureus. The company employs 72 people and targets multiple indications with its candidates AP-PA02, AP-PA03, and AP-SA02.
4 analysts think ARMP stock price will increase by 177.55%. The current median analyst target is $8.16 compared to a current stock price of $2.94. The lowest analysts target is $7.07 and the highest analyst target is $9.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
